top of page
Open Site Navigation

TIRmed Pharma receives approval of patent in the US

Uppdaterat: 8 mars 2022

TIRmed Pharma´s proprietary compound to treat inflammatory skin disorders was issued patent approval in the US, April 21st, 2020.

bottom of page